alpha-ergocryptine has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, CK; Chiusano, J; Goodrich-Smith, M; Moon, RC; Welsch, CW | 1 |
| Hussain, SP; Jannu, LN; Kumari, MV; Rao, AR | 1 |
2 other study(ies) available for alpha-ergocryptine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Topics: Adrenal Glands; Animals; Depression, Chemical; Drug Synergism; Ergolines; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Organ Size; Ovary; Pituitary Gland; Prolactin; Rats; Time Factors; Tretinoin | 1980 |
Modulatory influences of tamoxifen, tocopherol, retinyl acetate, aminoglutethimide, ergocryptine and selenium on DMBA-induced initiation of mammary carcinogenesis in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Animals; Diterpenes; Drug Interactions; Ergolines; Female; Mammary Neoplasms, Experimental; Rats; Retinyl Esters; Selenium; Tamoxifen; Vitamin A; Vitamin E | 1990 |